Microbial amphiphiles: A class of promising new-generation anticancer agents

Drug Discovery Today

Volumn 20, Issue 1, 2015, Pages 136-146

  Dey, Goutam ^a   Bharti, Rashmi ^a   Sen, Ramkrishna ^a   Mandal, Mahitosh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMPHOPHILE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; FELLUTAMIDE DERIVATIVE; FENGYCIN; GLYCOLIPID; ITURIN A; JANUS KINASE; LIPOPEPTIDE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PSEUDOFACTIN; RAKICIDIN; SOMATOMEDIN RECEPTOR; SOMOCYSTINAMIDE A; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SURFACTIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; BIOLOGICAL PRODUCT;

ANTINEOPLASTIC ACTIVITY; BIODEGRADABILITY; CELL CYCLE PROGRESSION; DRUG EFFECT; DRUG MECHANISM; MICROBACTERIUM; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; BACTERIUM; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; GLYCOLIPIDS; HUMANS; LIPOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84922463321     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.09.006     Document Type: Review

References (75)

1. Cragg, G.M. and Newman, D.J. (2005) Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100, 72-79
2. Hollstei, U. (1974) Actinomycin - chemistry and mechanism of action. Chem. Rev. 74, 625-652
3. Niraula, N.P. et al. (2010) Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production. Appl. Microbiol. Biotechnol. 87, 1187-1194
4. Gudina, E.J. et al. (2013) Potential therapeutic applications of biosurfactants. Trends Pharmacol. Sci. 34, 667-675
5. Sivapathasekaran, C. et al. (2010) Marine bacterium derived lipopeptides: characterization and cytotoxic activity against cancer cell lines. Int. J. Pept. Res. Ther. 16, 215-222
6. Wrasidlo, W. et al. (2008) The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc. Natl. Acad. Sci. U. S. A. 105, 2313-2318
7. Das, S. et al. (2012) Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS ONE 7, e46641
8. Rajput, S. et al. (2013) Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLOS ONE 8, e61342
9. Cao, X.H. et al. (2010) Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem. Biol. Interact. 183, 357-362
10. Liu, Y. et al. (2009) Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation. Mol. Pharmacol. 76, 91-104
11. Park, S.Y. et al. (2013) Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression. Int. J. Oncol. 42, 287-296
12. Mukherjee, S. et al. (2006) Towards commercial production of microbial surfactants. Trends Biotechnol. 24, 509-515
13. Sivapathasekaran, C. et al. (2010) Artificial neural network modeling and genetic algorithm based medium optimization for the improved production of marine biosurfactant. Bioresour. Technol. 101, 2884-2887
14. Sivapathasekaran, C. and Sen, R. (2013) Performance evaluation of an ANN-GA aided experimental modeling and optimization procedure for enhanced synthesis of marine biosurfactant in a stirred tank reactor. J. Chem. Technol. Biotechnol. 88, 794-799
15. Rangarajan, V. et al. (2012) Time-dependent dosing of Fe2+ for improved lipopeptide production by marine Bacillus megaterium. J. Chem. Technol. Biotechnol. 87, 1661-1669
16. Sivapathasekaran, C. and Sen, R. (2013) Performance evaluation of batch and unsteady state fed-batch reactor operations for the production of a marine microbial surfactant. J. Chem. Technol. Biotechnol. 88, 719-726
17. Liu, X.Y. et al. (2010) Effect of the microbial lipopeptide on tumor cell lines: apoptosis induced by disturbing the fatty acid composition of cell membrane. Protein Cell 1, 584-594
18. Hwang, Y.H. et al. (2007) Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock. Eur. J. Pharmacol. 556, 166-171
19. Ortiz, A. et al. (2009) Interactions of a bacterial biosurfactant trehalose lipid with phosphatidylserine membranes. Chem. Phys. Lipids 158, 46-53
20. Magetdana, R. and Ptak, M. (1995) Interactions of surfactin with membrane models. Biophys. J. 68, 1937-1943
21. Gonzalez-Aseguinolaza, G. et al. (2000) a-Galactosylceramide-activated Va14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. U. S. A. 97, 8461-8466
22. Vanittanakom, N. et al. (1986) Fengycin - a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J. Antibiot. 39, 888-901
23. Schneekloth, J.S. et al. (2006) Neurotrophic peptide aldehydes: solid phase synthesis of fellutamide B and a simplified analog. Bioorg. Med. Chem. Lett. 16, 3855-3858
24. Ma, D.W. et al. (2006) Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities. Chemistry 12, 7615-7626
25. Morita, M. et al. (1995) Structure-activity relationship of a-galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176-2187
26. Isoda, H. and Nakahara, T. (1997) Antiproliferative effect of polyol lipids, 3,5- dihydroxydecanoyl and 5-hydroxy-2-decenoyl esters of arabitol and mannitol on lung cancer cell line A549. J. Ferment. Bioeng. 84, 403-406
27. Zhao, X. et al. (2001) Protein kinase Ca plays a critical role in mannosylerythritol lipid-induced differentiation of melanoma B16 cells. J. Biol. Chem. 276, 39903-39910
28. Shao, L. et al. (2012) Bioactivities of sophorolipid with different structures against human esophageal cancer cells. J. Surg. Res. 173, 286-291
29. Sudo, T. et al. (2000) Induction of the differentiation of human HL-60 promyelocytic leukemia cell line by succinoyl trehalose lipids. Cytotechnology 33, 259-264
30. Sivapathasekaran, C. et al. (2010) Matrix assisted laser desorption ionization-time of flight mass spectral analysis of marine lipopeptides with potential therapeutic implications. Int. J. Pept. Res. Ther. 16, 79-85
31. Sivapathasekaran, C. et al. (2009) High-performance liquid chromatography purification of biosurfactant isoforms produced by a marine bacterium. Anal. Bioanal. Chem. 395, 845-854
32. Sen, R. (2010) Surfactin: biosynthesis, genetics and potential applications. Biosurfactants 672, 316-323
33. Steller, S. et al. (2004) Initiation of surfactin biosynthesis and the role of the SrfDthioesterase protein. Biochemistry 43, 11331-11343
34. Kameda, Y. et al. (1974) Antitumor activity of Bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem. Pharm. Bull. 22, 938-944
35. Cao, X.H. et al. (2009) Purification and antitumour activity of a lipopeptide biosurfactant produced by Bacillus natto TK-1. Biotechnol. Appl. Biochem. 52, 97-106
36. Cao, X.H. et al. (2009) Surfactin induces apoptosis and G(2)/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochem. Biophys. 55, 163-171
37. Kim, S.Y. et al. (2007) Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett. 581, 865-871
38. Lee, J.H. et al. (2012) The production of surfactin during the fermentation of cheonggukjang by potential probiotic Bacillus subtilis CSY191 and the resultant growth suppression of MCF-7 human breast cancer cells. Food Chem. 131, 1347-1354
39. Yu, G.Y. et al. (2002) Production of iturin A by Bacillus amyloliquefaciens suppressing Rhizoctonia solani. Soil Biol. Biochem. 34, 955-963
40. Nasir, M.N. and Besson, F. (2012) Conformational analyses of bacillomycin D, a natural antimicrobial lipopeptide, alone or in interaction with lipid monolayers at the air-water interface. J. Colloid Interface Sci. 387, 187-193
41. Trischman, J.A. et al. (1994) Halobacillin - a cytotoxic cyclic acylpeptide of the iturin class produced by a marine Bacillus. Tetrahedron Lett. 35, 5571-5574
42. Zhang, H.L. et al. (2004) Three new cytotoxic cyclic acylpeptides from marine Bacillus sp.. Chem. Pharm. Bull. 52, 1029-1030
43. Suyama, T.L. and Gerwick, W.H. (2008) Stereospecific total synthesis of somocystinamide A. Org. Lett. 10, 4449-4452
44. Lee, Y.M. et al. (2011) A cytotoxic fellutamide analogue from the sponge-derived fungus Aspergillus versicolor. Bull. Korean Chem. Soc. 32, 3817-3820
45. Shigemori, H. et al. (1991) Fellutamide-A and fellutamide-B, cytotoxic peptides from a marine fish-possessing fungus Penicillium fellutanum. Tetrahedron 47, 8529-8534
46. Lee, Y.M. et al. (2010) A cytotoxic lipopeptide from the sponge-derived fungus Aspergillus versicolor. Bull. Korean Chem. Soc. 31, 205-208
47. Xu, D.M. et al. (2011) Isolation, structure, and biological activities of fellutamides C and D from an undescribed Metulocladosporiella (Chaetothyriales) using the genomewide Candida albicans fitness test. J. Nat. Prod. 74, 1721-1730
48. Janek, T. et al. (2013) Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. PLOS ONE 8, e57991
49. Takeuchi, M.I. (2011) Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr-Abl positive leukemic cells. Cancer Sci. 102, 591-596
50. Xie, J.J. et al. (2011) FW523-3, a novel lipopeptide compound, induces apoptosis in cancer cells. Mol. Med. Rep. 4, 759-763
51. Yamazaki, Y. et al. (2007) Rakicidin A: a hypoxia-selective cytotoxin. Biol. Pharm. Bull. 30, 261-265
52. Wilson, W.R. and Hay, M.P. (2011) Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393-410
53. Poulsen, T.B. (2011) A concise route to the macrocyclic core of the rakicidins. Chem. Commun. 47, 12837-12839
54. Nunnery, J.K. et al. (2010) Biologically active secondary metabolites from marine cyanobacteria. Curr. Opin. Biotechnol. 21, 787-793
55. Thornburg, C.C. et al. (2013) Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens. J. Nat. Prod. 76, 1781-1788
56. Robertson, B.D. et al. (2012) Asymmetric total synthesis of apratoxin D. Org. Lett. 14, 5192-5195
57. Tidgewell, K. et al. (2010) Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. ChemBioChem 11, 1458-1466
58. Chen, Q.Y. et al. (2011) Systematic chemical mutagenesis identifies a potent novel apratoxin A/E hybrid with improved in vivo antitumor activity. ACS Med. Chem. Lett. 2, 861-865
59. Karanth, N.G.K. et al. (1999) Microbial production of biosurfactants and their importance. Curr. Sci. 77, 116-126
60. Fuji, N. et al. (2000) Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Clin. Cancer Res. 6, 3380-3387
61. Nakui, M. et al. (2000) Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1. Clin. Exp. Metastasis 18, 147-153
62. Hayakawa, Y. et al. (2001) Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alphagalactosylceramide. Eur. J. Immunol. 31, 1720-1727
63. Schneiders, F.L. et al. (2011) Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clin. Immunol. 140, 130-141
64. Ishikawa, A. et al. (2005) A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 11, 1910-1917
65. Giaccone, G. et al. (2002) A phase I study of the natural killer T-cell ligand agalactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8, 3702-3709
66. Yamasaki, K. et al. (2011) Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clin. Immunol. 138, 255-265
67. Nieda, M. et al. (2004) Therapeutic activation of Va24 + Vb11 + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103, 383-389
68. Kunii, N. et al. (2009) Combination therapy of in vitro-expanded natural killer T cells and a-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci. 100, 1092-1098
69. Maeda, N. et al. (2007) Anti-tumor effects of the glycolipids fraction from spinach which inhibited DNA polymerase activity. Nutr. Cancer 57, 216-223
70. Farokhi, F. et al. (2012) Antiproliferative activity against human non-small cell lung cancer of two O-alkyl-diglycosylglycerols from the marine sponges Myrmekioderrna dendyi and Trikentrion laeve. Eur. J. Med. Chem. 49, 406-410
71. Morita, T. et al. (2006) Discovery of Pseudozyma rugulosa NBRC 10877 as a novel producer of the glycolipid biosurfactants, mannosylerythritol lipids, based on rDNA sequence. Appl. Microbiol. Biotechnol. 73, 305-313
72. Kitamoto, D. et al. (2002) Functions and potential applications of glycolipid biosurfactants - from energy-saving materials to gene delivery carriers. J. Biosci. Bioeng. 94, 187-201
73. Isoda, H. and Nakahara, T. (1997) Mannosylerythritol lipid induces granulocytic differentiation and inhibits the tyrosine phosphorylation of human myelogenous leukemia cell line K562. Cytotechnology 25, 191-195
74. Zhao, X.X. et al. (1999) Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture. Cancer Res. 59, 482-486
75. Fu, S.L. et al. (2008) Sophorolipids and their derivatives are lethal against human pancreatic cancer cells. J. Surg. Res. 148, 77-82